Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Safety and Efficacy of the Alpha AMS Subretinal Implant [NA]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy of the Alpha AMS subretinal implant in Retinitis Pigmentosa and notes that the study has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha AMS Subretinal Implant

Snippet

Sponsor: University of Oxford | Conditions: Retinitis Pigmentosa | NA | Status: COMPLETED